Stay up to date by subscribing to our latest press releases.
We believe we have an important role to fill in society – bringing new, innovative treatments to patients with rare diseases.
Focus areas are within genetic & metabolic diseases, hematology & oncology and specialty care.
We operate products from phase 2 and all the way to mature products.
ESG is an integrated part of our business model.
Stay up to date with our latest news.
Telephone: +46 (0) 8 533 39 500 E-mail: [email protected]